APT Medical Inc (688617) — Cash Flow Reinvestment Rate
APT Medical Inc (688617) has a Cash Flow Reinvestment Rate of 0.67x as of December 2025, reinvesting CN¥196.93 Million (capex CN¥52.10 Million plus investments CN¥144.83 Million) from operating cash flow of CN¥294.68 Million. See APT Medical Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
APT Medical Inc Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for APT Medical Inc across 9 annual periods. For the full cash flow conversion analysis, see 688617 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for APT Medical Inc (2017–2025)
Year-by-year capital reinvestment analysis for APT Medical Inc. See APT Medical Inc (688617) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | CN¥501.12 Million | CN¥975.30 Million | CN¥285.59 Million | ▼ -43.9% |
| 2024 | 0.92x | CN¥681.04 Million | CN¥743.39 Million | CN¥650.24 Million | ▼ -19.5% |
| 2023 | 1.14x | CN¥783.93 Million | CN¥689.06 Million | CN¥202.03 Million | ▲ +50.5% |
| 2022 | 0.76x | CN¥277.73 Million | CN¥367.46 Million | CN¥143.21 Million | ▼ -89.3% |
| 2021 | 7.04x | CN¥1.28 Billion | CN¥181.39 Million | CN¥167.38 Million | ▲ +2223.6% |
| 2020 | 0.30x | CN¥44.93 Million | CN¥148.24 Million | CN¥44.20 Million | ▼ -87.7% |
| 2019 | 2.47x | CN¥135.59 Million | CN¥54.90 Million | CN¥67.56 Million | ▲ +42.9% |
| 2018 | 1.73x | CN¥32.20 Million | CN¥18.63 Million | CN¥32.20 Million | ▼ -11.7% |
| 2017 | 1.96x | CN¥25.26 Million | CN¥12.91 Million | CN¥25.26 Million | — |